Search

everythinglearnresearchcommunity

for

Search:↓

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

DHT, a testosterone byproduct, causes male pattern baldness.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Hormonal therapies are safe and effective for treating adult women's acne.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Menopause affects hair and skin; more research needed for treatment.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.